EUCTR2018-002842-35-FR进行中（未招募）1 期
Interest of parasternal block to prevent hypertensive and tachycardia episodes during sternotomy in patients undergoing coronary artery bypass graft - PARA
CMC Ambroise Paré0 个研究点目标入组 35 人开始时间: 2018年8月28日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- 18 Years and older
- •- Patients undergoing coronary artery bypass graft requiring sternotomy other than re-interventions and combined surgeries
- •- Consent for participation
- •- Affiliation to the french social security system
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 15
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 15
排除标准
- •- Pregnant or breastfeeding women
- •- Patients under protection of the adults (guardianship, curator or safeguard of justice)
- •- Communication difficulties or neuropsychiatric disorder
- •- Neuropathic disease
- •- Constitutional coagulation disorders
- •- Kidney insufficiency
- •- Sensitivity to nonsteroidal anti-inflammatory drugs
- •- Hypersensitivity to local anaesthetics
- •- Chronic use of opioid analgesics
- •- Corticosteroid treatment or immunosuppressive therapy
- •- Autoimmune disease
- •- Chronic pain syndrome or fibromyalgia
- •- Emergency cardiac surgery
- •- Hypovolemia
研究者
相似试验
招募中
不适用
Digital preventive measures for arterial hypertensioI10-I15Hypertensive diseasesDRKS00029761Medizinische Hochschule Brandenburg Campus GmbH2,510
已完成
不适用
Aggressive antihypertensive treatment for protecting cardiovascular complications in pre-diabetic hypertensive patients1.Hypertensive patients with diabetes mellitus (DM), pre-diabetes: DM was defined as at least one of the following criteria: fasting blood glucose >=126mg/dl, 2-hour glucose in 75gOGTT >=200mg/dl, HbA1c >=6.1%, or treated diabetes.Pre-diabetes was diagnosed as HbA1c >=5.7%JPRN-UMIN000005541Jichi Medical University School of Medicine60
已完成
不适用
Aggressive antihypertensive treatment for protecting cardiovascular complications in diabetic and pre-diabetic hypertensive patients1.Hypertensive patients with diabetes mellitus (DM), pre-diabetes: DM was defined as at least one of the following criteria: fasting blood glucose >=126mg/dl, 2-hour glucose in 75gOGTT >=200mg/dl, HbA1c >=6.1%, or treated diabetes.Pre-diabetes was diagnosed as HbA1c >=5.7%JPRN-UMIN000005743Jichi Medical University,School of Medicine60
招募中
不适用
The effect of giving a Drug to block nerves supplying Kidneys to reduce Blood loss during Surgery for removal of Kidney Stones.CTRI/2020/09/027909RajaRajeswari Medical College and Hospital
进行中（未招募）
不适用
Prevención de la progresión de la hipertensión portal en la cirrosis compensada mediante el uso de vasodilatadores hepáticos selectivos. Estudio multicéntrico, aleatorizado y doble-ciego - SIMPROEl objetivo de estudio es valorar el efecto de las estatinas, en su efecto vasodilatador selectivo hepático, en la prevención de la progresión de la hipertensión portal ( con un gradiente de presión entre 6 y 10 mmHg) en pacientes con cirrosis hepática compensada.MedDRA version: 12.1Level: HLTClassification code 10036201Term: Portal hypertensionsEUCTR2010-021593-11-ESINSTITUT DE RESERCA.HSCSP